Kaplan–Meier analysis and log-rank testing revealed that SMC4 protein expression levels in glioma specimens were inversely correlated with survival time, whether at WHO grades I–II or at WHO grades III–IV (Figure 2d). This evidence concerns the gene SMC4 and central nervous system cancer.